TL1A - Search Videos

Marla Dubinsky, MD / Bruce Sands, MD, MS - Evolving Methods for Precision Care in IBD Management and Targeting TL1A

Marla Dubinsky, MD / Bruce Sands, MD, MS - Evolving Methods for Precision Care in IBD Management and Targeting TL1A

Evolving Methods for Precision Care in IBD Management and Targeting TL1A

Evolving Methods for Precision Care in IBD Management and Targeting TL1A

486 views10 months ago

YouTubePeerView CME

TL1A Expression in Human IBD and Animal Models - SlideServe

TL1A Expression in Human IBD and Animal Models - SlideServe

UChicago Advances IBD Trials With Focus on Microbiome and Access | HCPLive

UChicago Advances IBD Trials With Focus on Microbiome and Access | HCPLive

Diane Mathis (Harvard) 1: An Introduction to T Cell Tolerance

Diane Mathis (Harvard) 1: An Introduction to T Cell Tolerance

40K viewsMar 1, 2017

YouTubeScience Communication Lab

New Anti TL1A Antibody Could Transform Crohn’s Disease Treatment #shorts

New Anti TL1A Antibody Could Transform Crohn’s Disease Treatment #shorts

181 views5 months ago

YouTubeV Creatives

自己免疫疾患関連マウスモデル：最新の進歩と応用

自己免疫疾患関連マウスモデル：最新の進歩と応用

35 views9 months ago

YouTubeバイオサイトジェン

Prometheus Biosciences Announces Positive Results for Pra023 in Both Artemis-UC Phase 2 and Apollo-Cd Phase 2A Studies Enabling Pathway to Both First-In-Class and Best-In-Class Anti-Tl1a Mab

marketscreener.com

Epithelial alarmin TL1A is a co-factor of IL-33

602 viewsApr 10, 2024

YouTubeJournal of Experimental Medicine

Merck & Co., Inc.: Merck to Present New Long-Term Data for Tulisokibart (MK-7240), an Investigational Anti-TL1A Monoclonal Antibody, in Inflammatory Bowel Disease at UEG Week 2024

finanznachrichten.de

PMC BREAKING | 17.1亿美元！艾伯维引进明济生物临床前TL1A单抗

237 viewsJun 14, 2024

bilibili医药魔方

Cell-Mediated (Cellular) Immunity [aka T-cell immunity] - Physiology & Immunology

187.6K viewsDec 25, 2021

YouTubeMedicosis Perfectionalis

Absci Corporation: Absci Announces First Participants Dosed in Phase 1 Clinical Trial of ABS-101, a Potential Best-In-Class anti-TL1A Antibody for the Treatment of Inflammatory Bowel Disease

finanznachrichten.de

Xencor annonce des résultats intermédiaires positifs de la première étude chez l'homme sur Xmab942, un anticorps anti-Tl1a à haute puissance et à demi-vie prolongée, en cours de développement pour le traitement des maladies inflammatoires de l'intestin.

Vial Initiates Phase 1 Trial of Anti-TL1A Antibody | Thomas McAlear, PhD

Cell Signaling Overview Animation

26.5K viewsJun 15, 2022

YouTubeHeather Scherr

For patients with moderately to severely active ulcerative colitis, the efficacy and safety of the anti-TL1A monoclonal antibody tulisokibart is unknown. Results of a phase 2 trial are summarized in a new Quick Take video. https://nej.md/4gCAts6 | The New England Journal of Medicine

1.7K viewsSep 29, 2024

FacebookThe New England Journal of Medicine

#MondayNightIBD IBD Clinical Trials to Watch: Anti-TL1As & mir124 enhancers

469 views7 months ago

YouTubeBonum Continuing Education

Spyre Therapeutics administre la première dose à un patient dans l'essai de phase 2 SKYway, une étude pionnière de l'anticorps anti-TL1A SPY072 dans les maladies rhumatismales

Absci Corporation to Present Preclinical Data for ABS-101, A Potential Best-In-Class Anti-TL1A Antibody Development Program, at 42nd Annual J.P. Morgan Healthcare Conference

marketscreener.com

Common cell signaling pathway

837.1K viewsOct 14, 2020

YouTubeOsmosis from Elsevier

Is TL1A a Cytokine That Is Involved in Arthritis Inflammation? | Rheumatoid Arthritis Wellness Guide

16 views8 months ago

YouTubeRheumatoid Arthritis Wellness Guide

Teva Pharmaceutical Industries Ltd: Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn's Disease

finanznachrichten.de

What is TL1? What is the relation between TL1 and SNMP, CMIP, a... | Filo

5.7K views11 months ago

Role of TL-1A/DR3 in Intestinal Inflammation

1.2K viewsFeb 9, 2018

YouTubeFralin Biomedical Research Institute

IBD - its drugs and recent advances

3 views2 weeks ago

YouTubeMedicosphere

Immunology Update – 8 April 2026: Rezurock EU Approval, Fabhalta Phase 3 and More

YouTubeLucidQuest

Spyre Therapeutics, Inc.: Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver 9 Phase 2 Readouts

finanznachrichten.de

Operative Strategies in Inflammatory Bowel Disease (IBD)

35.6K viewsDec 6, 2019

YouTubeJohns Hopkins Medicine

Ulcerative colitis: Fresh approaches to taming inflammation

216.7K viewsNov 7, 2018

YouTubenature video

See more